TY - JOUR
T1 - Deep Neuromuscular Blockade Improves Laparoscopic Surgical Conditions
T2 - A Randomized, Controlled Study
AU - Rosenberg, Jacob
AU - Herring, W Joseph
AU - Blobner, Manfred
AU - Mulier, Jan P
AU - Rahe-Meyer, Niels
AU - Woo, Tiffany
AU - Li, Michael K
AU - Grobara, Peter
AU - Assaid, Christopher A
AU - Fennema, Hein
AU - Szegedi, Armin
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Introduction: Sustained deep neuromuscular blockade (NMB) during laparoscopic surgery may facilitate optimal surgical conditions. This exploratory study assessed whether deep NMB improves surgical conditions and, in doing so, allows use of lower insufflation pressures during laparoscopic cholecystectomy. We further assessed whether use of low insufflation pressure improves patient pain scores after surgery. Methods: This randomized, controlled, blinded study (NCT01728584) compared use of deep (1–2 post-tetanic-counts) or moderate (train-of-four ratio 10%) NMB, and lower (8 mmHg) or higher (12 mmHg; ‘standard’) insufflation pressure in a 2 × 2 factorial design. Primary endpoint was surgeon’s overall satisfaction with surgical conditions, rated at end of surgery using an 11-point numerical scale. Post-operative pain scores were also evaluated. Data were analyzed using analysis of covariance. Results: Of 127 randomized patients, 120 had evaluable data for the primary endpoint. Surgeon’s score of overall satisfaction with surgical conditions was significantly higher with deep versus moderate NMB indicated by a least-square mean difference of 1.1 points (95% confidence interval 0.1–2.0; P = 0.026). Furthermore, strong evidence of an effect was observed for standard versus low pressure: least-square mean difference of 3.0 points (95% confidence interval 2.1–4.0; P < 0.001). No significant difference was observed in average pain scores within 24 h post-surgery for low versus standard pressure [0.17 (95% confidence interval −0.67 to +0.33); P = 0.494]. Conclusions: Although associated with significantly improved surgical conditions, deep NMB alone was insufficient to promote use of low insufflation pressure during laparoscopic cholecystectomy. Furthermore, low insufflation pressure did not result in reduced pain, compared with standard pressure. Clinical Trial Registration: ClinicalTrials.gov identifier, NCT01728584. Funding: Merck Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
AB - Introduction: Sustained deep neuromuscular blockade (NMB) during laparoscopic surgery may facilitate optimal surgical conditions. This exploratory study assessed whether deep NMB improves surgical conditions and, in doing so, allows use of lower insufflation pressures during laparoscopic cholecystectomy. We further assessed whether use of low insufflation pressure improves patient pain scores after surgery. Methods: This randomized, controlled, blinded study (NCT01728584) compared use of deep (1–2 post-tetanic-counts) or moderate (train-of-four ratio 10%) NMB, and lower (8 mmHg) or higher (12 mmHg; ‘standard’) insufflation pressure in a 2 × 2 factorial design. Primary endpoint was surgeon’s overall satisfaction with surgical conditions, rated at end of surgery using an 11-point numerical scale. Post-operative pain scores were also evaluated. Data were analyzed using analysis of covariance. Results: Of 127 randomized patients, 120 had evaluable data for the primary endpoint. Surgeon’s score of overall satisfaction with surgical conditions was significantly higher with deep versus moderate NMB indicated by a least-square mean difference of 1.1 points (95% confidence interval 0.1–2.0; P = 0.026). Furthermore, strong evidence of an effect was observed for standard versus low pressure: least-square mean difference of 3.0 points (95% confidence interval 2.1–4.0; P < 0.001). No significant difference was observed in average pain scores within 24 h post-surgery for low versus standard pressure [0.17 (95% confidence interval −0.67 to +0.33); P = 0.494]. Conclusions: Although associated with significantly improved surgical conditions, deep NMB alone was insufficient to promote use of low insufflation pressure during laparoscopic cholecystectomy. Furthermore, low insufflation pressure did not result in reduced pain, compared with standard pressure. Clinical Trial Registration: ClinicalTrials.gov identifier, NCT01728584. Funding: Merck Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
KW - Adult
KW - Cholecystectomy, Laparoscopic/methods
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Neuromuscular Blockade/methods
KW - Pain, Postoperative/epidemiology
KW - Single-Blind Method
U2 - 10.1007/s12325-017-0495-x
DO - 10.1007/s12325-017-0495-x
M3 - Journal article
C2 - 28251555
SN - 0741-238X
VL - 34
SP - 925
EP - 936
JO - Advances in Therapy
JF - Advances in Therapy
IS - 4
ER -